| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/20/2010 | US7700296 Kit comprising monoclonal antibodies directed against an epitope; determining level in serum for diagnosis of coronary atherosclerosis, vascular calcification, angiogenesis, diabetes |
| 04/20/2010 | US7700294 Method of isolating cytotoxic heterocomplex associated with multiple sclerosis |
| 04/20/2010 | US7700274 Compositions and methods in cancer associated with altered expression of KCNJ9 |
| 04/20/2010 | US7700272 Ligand gated chloride channel for use as screening tool in identifying/screening pesticidal and antiparasitic agents |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700119 85kDa neisserial antigen |
| 04/20/2010 | US7700117 Camp factor of Streptococcus uberis |
| 04/20/2010 | US7700109 Biomolecule transduction motif Mph-1-BTM and the use thereof |
| 04/20/2010 | US7700107 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 04/20/2010 | US7700106 Therapeutic agent for ulcerative colitis |
| 04/20/2010 | US7700104 Attenuated Salmonella SP12 mutants as antigen carriers |
| 04/20/2010 | US7700102 Stimulant immunology response; prevent infections |
| 04/20/2010 | US7700101 modulating lipid levels and/or bone mass; diagnosis of abnormal lipid levels and bone mass disorders, such as osteoporosis; bone disorders; Paget's disease |
| 04/20/2010 | US7700100 FcγRIIB fusion proteins and compositions thereof |
| 04/20/2010 | US7700099 Non-immunostimulatory antibody and compositions containing the same |
| 04/20/2010 | US7700097 Purification and preferential synthesis of binding molecules |
| 04/20/2010 | US7700096 Medicinal agent for treating erectile dysfunction |
| 04/20/2010 | US7700088 Interleukin-9 mutein peptides |
| 04/20/2010 | US7700085 Administering an agent which inhibits binding of advanced glycation endproducts to any of their receptors; wound healing |
| 04/20/2010 | CA2515366C Compositions and methods to modulate immune and inflammatory responses |
| 04/20/2010 | CA2352572C Humanized antibodies to gamma-interferon |
| 04/20/2010 | CA2330549C Diacylglycerol o-acyltransferase |
| 04/20/2010 | CA2318486C Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
| 04/20/2010 | CA2219876C Stable variant hk2 polypeptide |
| 04/20/2010 | CA2212702C Mucosal vascular addressins and uses thereof |
| 04/20/2010 | CA2191884C Novel glycoglycerophospholipid, antibody thereagainst, and method for detecting mycoplasma |
| 04/20/2010 | CA2181433C Materials and methods for management of hyperacute rejection in human xenotransplantation |
| 04/20/2010 | CA2155303C Treatment for insulin dependent diabetes |
| 04/20/2010 | CA2134756C Selectin variants |
| 04/15/2010 | WO2010042904A2 Tcr complex immunotherapeutics |
| 04/15/2010 | WO2010042815A2 Vhh antibody fragments for use in the detection and treatment of cancer |
| 04/15/2010 | WO2010042741A1 Methods of making concentrated fibrinogen- and platelet containing compositions |
| 04/15/2010 | WO2010042697A1 Regulation of lymphocytes and uses therefor |
| 04/15/2010 | WO2010042481A1 Compositions and methods related to bacterial eap, emp, and/or adsa proteins |
| 04/15/2010 | WO2010042202A1 Methods for treatment of podocyte injury |
| 04/15/2010 | WO2010042201A1 Methods for treatment of focal segmental glomerulosclerosis |
| 04/15/2010 | WO2010041938A2 New virulence factors of streptococcus pneumoniae |
| 04/15/2010 | WO2010041892A2 Novel application of aimp1 polypeptide |
| 04/15/2010 | WO2010041742A1 Method for introducing dota |
| 04/15/2010 | WO2010041060A1 Targeted binding agents directed to heparanase and uses thereof 463 |
| 04/15/2010 | WO2010040988A1 Purification process for fragment antibodies |
| 04/15/2010 | WO2010040766A1 Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (pf4v1) |
| 04/15/2010 | WO2010040737A1 Epitopes derived from satb2 and uses thereof |
| 04/15/2010 | WO2010040736A2 Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling |
| 04/15/2010 | WO2010040572A2 Antibodies |
| 04/15/2010 | WO2010040545A1 Proteolytically stable antibody formats |
| 04/15/2010 | WO2010040508A1 Bispecific anti-vegf/anti-ang-2 antibodies |
| 04/15/2010 | WO2010040362A1 Antibodies against rns-induced modified cytokines and uses thereof |
| 04/15/2010 | WO2010040281A1 Humanized antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| 04/15/2010 | WO2010040209A1 Methods and systems for predicting misfolded protein epitopes |
| 04/15/2010 | WO2010040175A1 Amyloid-beta peptide crystal structure |
| 04/15/2010 | WO2010017332A3 Radioprotectants targeting thrombospondin-1 and cd47 |
| 04/15/2010 | WO2010002911A3 Methods and materials for monitoring myeloma using quantitative mass spetrometry |
| 04/15/2010 | WO2009150426A3 Cloning of antibody genes using unique restrictions sites |
| 04/15/2010 | WO2009135118A9 Lyme disease vaccine |
| 04/15/2010 | WO2009118660A4 Adam-15 antibodies and immunogenic peptides |
| 04/15/2010 | US20100095400 Nucleic Acid Molecules and Other Molecules Associated with the Cytokinin Pathway |
| 04/15/2010 | US20100095398 Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/15/2010 | US20100095397 Polynucleotides and methods for the improvement of plants |
| 04/15/2010 | US20100095390 Aldolases, Nucleic Acids Encoding Them and Methods for Making and Using Them |
| 04/15/2010 | US20100093981 Carbamoylation of amines, thiophenols, mercaptanes and phenols employing organic azides |
| 04/15/2010 | US20100093980 Methods of Humanizing Immunoglobulin Variable Regions Through Rational Modification Of Complementarity Determining Residues |
| 04/15/2010 | US20100093979 Fc Polypeptides With Novel Fc Ligand Binding Sites |
| 04/15/2010 | US20100093978 Dkk-related proteins |
| 04/15/2010 | US20100093977 Altered Antibodies |
| 04/15/2010 | US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera |
| 04/15/2010 | US20100093831 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 04/15/2010 | US20100093642 Novel polypeptides |
| 04/15/2010 | US20100093630 Mammalian chemokines; related reagents |
| 04/15/2010 | US20100093108 Lung cancer diagnotic assay |
| 04/15/2010 | US20100093076 Soluble il-27 receptor |
| 04/15/2010 | US20100093056 Antibodies that bind dkk-related proteins |
| 04/15/2010 | US20100093039 Cell Culture Media for Enhanced Protein Production |
| 04/15/2010 | US20100093038 Means and Methods for Influencing the Stability of Cells |
| 04/15/2010 | US20100093027 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 04/15/2010 | US20100093008 Phospho-specific antibodies to flt3 (tyr969) and uses thereof |
| 04/15/2010 | US20100093006 High affinity anti-n1,n12-diacetylspermine monoclonal antibody |
| 04/15/2010 | US20100093005 Identifying duct cancers |
| 04/15/2010 | US20100093003 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 04/15/2010 | US20100093000 Tyrosine phosphorylation sites |
| 04/15/2010 | US20100092997 Method of Enhancing of Binding Activity of Antibody Composition to FcGamma Receptor IIIa |
| 04/15/2010 | US20100092994 High specificity monoclonal antibody against a protein or a polypeptide having oxidative modification |
| 04/15/2010 | US20100092992 Lysine acetylation sites |
| 04/15/2010 | US20100092978 Cadherin-17 as diagnostic marker and therapeutic target for liver cancer |
| 04/15/2010 | US20100092975 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer |
| 04/15/2010 | US20100092941 32142,21481,25964,21686, Novel dehydrogenase molecules and uses therefor |
| 04/15/2010 | US20100092520 Recombinant Plasmodium Falciparum Merozoite Surface Proteins 4 and 5 and Their Use |
| 04/15/2010 | US20100092508 Molecular Antigen Arrays |
| 04/15/2010 | US20100092496 drug-ligand conjugates that are potent cytotoxins; stabilized therapeutic agents and markers; exhibit high specificity of action, reduced toxicity, and improved stability in blood ; antitumors |
| 04/15/2010 | US20100092495 Potent cell-binding agent drug conjugates |
| 04/15/2010 | US20100092494 Composition and method for facilitating the internalization of a therapeutic agent into a cell |
| 04/15/2010 | US20100092492 Vascular endothelial cell growth factor antagonists |
| 04/15/2010 | US20100092491 Anti-epcam antibody and uses thereof |
| 04/15/2010 | US20100092487 Toxic detection method |
| 04/15/2010 | US20100092484 Cd44 antibodies |
| 04/15/2010 | US20100092482 Compositions monovalent for CD40L binding and methods of use |
| 04/15/2010 | US20100092481 Human cytomegalovirus neutralising antibodies and use thereof |
| 04/15/2010 | US20100092480 Modulators of protein phosphatase 2a |
| 04/15/2010 | US20100092477 Methods and compositions for treating prostate cancer |
| 04/15/2010 | US20100092473 Anti-phospho-akt antibodies |